Cell cycle–related kinase is a direct androgen receptor–regulated gene that drives β-catenin/T cell factor–dependent hepatocarcinogenesis
Hai Feng(Chinese University of Hong Kong), Joseph J.�Y. Sung(Nanyang Technological University), Guijun Zhao(Inner Mongolia People's Hospital), May S. Li, Ka‐Fai To(Chinese University of Hong Kong), Alfred S.L. Cheng(Chinese University of Hong Kong), Jun Yu(Yueyang Second People's Hospital), Samuel S. Ng(University of Hong Kong), Marie C. Lin(Chinese University of Hong Kong), Daisy P. Tsang(Therapeutics Clinical Research), Paul B.S. Lai(Chinese University of Hong Kong), Minnie Y.Y. Go(Therapeutics Clinical Research), Yue S. Cheung(Chinese University of Hong Kong)
Cited by 138
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830